Pathologists have made much progress in understanding the diversity — and to some extent, the aggressiveness — of different renal cell carcinoma (RCC) tumors. But a key gap remains the ability to ...
A pilot, open-label phase II study of sorafenib combined with cisplatin plus gemcitabine for the treatment of patients with advanced renal collecting duct carcinoma. This is an ASCO Meeting Abstract ...
Randomized phase III trial of adjuvant pazopanib versus placebo after nephrectomy in patients with locally advanced renal cell carcinoma (RCC) (PROTECT). DNA damage repair and response (DDR) gene ...
Metastatic renal cell carcinoma (RCC) is a type of kidney cancer that has spread to other body parts. Depending on where it spreads, it can cause shortness of breath, bone pain, or jaundice. RCC is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results